Background Patients with asthma who have aspirin sensitivityhave greater cysteinyl leukotriene production and greater airwayhyperresponsiveness to the effects of inhaled cysteinyl leukotrienesthan their aspirin-tolerant counterparts. We hypothesized thatthe latter effect reflects elevated expression of the cysteinylleukotriene receptor CysLT1 on inflammatory cells in the targetorgan and that its expression is down-regulated by aspirin desensitization.
Methods We obtained nasal-biopsy specimens from 22 aspirin-sensitiveand 12 nonaspirin-sensitive patients with chronic rhinosinusitisand nasal polyps. Additional specimens were then obtained fromsubgroups of the aspirin-sensitive patients after intranasalapplication of lysine aspirin or placebo for two weeks (fiveand four patients, respectively) or for six months (five andfour patients, respectively). The numbers of leukocytes expressingthe CysLT1 and leukotriene B4 (LTB4) receptors per unit areaof sections of the nasal submucosa were determined by immunohistochemistry.
Results The absolute number of cells expressing the CysLT1 receptorwas significantly higher in the aspirin-sensitive patients thanin the nonaspirin-sensitive patients (median, 542 cellsper square millimeter [range, 148 to 1390] vs. 116 cells persquare millimeter [range, 40 to 259]; P<0.001). The percentageof CD45+ leukocytes expressing the CysLT1 receptor was alsohigher in the aspirin-sensitive subjects (25 percent of CD45+leukocytes [range, 4 to 50] vs. 5 percent of CD45+ leukocytes[range, 2 to 11]; P<0.001); the percentage of CD45+ leukocytesexpressing the LTB4 receptor did not differ significantly betweenthese two groups. Desensitization was associated with a decreasein the numbers of inflammatory cells expressing CysLT1.
Conclusions The elevated numbers of nasal inflammatory leukocytesexpressing the CysLT1 receptor in aspirin-sensitive patientswith chronic rhinosinusitis as compared with their nonaspirin-sensitivecounterparts and the down-regulation of receptor expressionafter desensitization to aspirin are probably fundamental inthe pathogenesis of aspirin sensitivity and in the mechanismof aspirin desensitization.
Source Information
From Guy's, King's and St. Thomas' School of Medicine (A.R.S., C.J.C., T.H.L.) and the Royal National Throat, Nose and Ear Hospital (A.P., G.S.) both in London.
Address reprint requests to Dr. Lee at the Department of Asthma, Allergy and Respiratory Science, Guy's Hospital, London SE1 9RT, United Kingdom, or at tak.lee{at}kcl.ac.uk.
Paruchuri, S., Jiang, Y., Feng, C., Francis, S. A., Plutzky, J., Boyce, J. A.
(2008). Leukotriene E4 Activates Peroxisome Proliferator-activated Receptor {gamma} and Induces Prostaglandin D2 Generation by Human Mast Cells. J. Biol. Chem.
283: 16477-16487
[Abstract][Full Text]
Peters-Golden, M., Henderson, W. R. Jr.
(2007). Leukotrienes. NEJM
357: 1841-1854
[Full Text]
Knowles, S. R, Drucker, A. M, Weber, E. A, Shear, N. H
(2007). Management Options for Patients with Aspirin and Nonsteroidal Antiinflammatory Drug Sensitivity. The Annals of Pharmacotherapy
41: 1191-1200
[Abstract][Full Text]
Early, S. B., Barekzi, E., Negri, J., Hise, K., Borish, L., Steinke, J. W.
(2007). Concordant Modulation of Cysteinyl Leukotriene Receptor Expression by IL-4 and IFN-{gamma} on Peripheral Immune Cells. Am. J. Respir. Cell Mol. Bio.
36: 715-720
[Abstract][Full Text]
Lee, S.-H., Rhim, T., Choi, Y.-S., Min, J.-W., Kim, S.-H., Cho, S.-Y., Paik, Y.-K., Park, C.-S.
(2006). Complement C3a and C4a Increased in Plasma of Patients with Aspirin-induced Asthma. Am. J. Respir. Crit. Care Med.
173: 370-378
[Abstract][Full Text]
Weller, C. L., Collington, S. J., Brown, J. K., Miller, H. R.P., Al-Kashi, A., Clark, P., Jose, P. J., Hartnell, A., Williams, T. J.
(2005). Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors. JEM
201: 1961-1971
[Abstract][Full Text]
Jinnai, N., Sakagami, T., Sekigawa, T., Kakihara, M., Nakajima, T., Yoshida, K., Goto, S., Hasegawa, T., Koshino, T., Hasegawa, Y., Inoue, H., Suzuki, N., Sano, Y., Inoue, I.
(2004). Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach. Hum Mol Genet
13: 3203-3217
[Abstract][Full Text]
Kanaoka, Y., Boyce, J. A.
(2004). Cysteinyl Leukotrienes and Their Receptors: Cellular Distribution and Function in Immune and Inflammatory Responses. J. Immunol.
173: 1503-1510
[Abstract][Full Text]
Yang, G., Haczku, A., Chen, H., Martin, V., Galczenski, H., Tomer, Y., Van Beisen, C. R., Evans, J. F., Panettieri, R. A., Funk, C. D.
(2004). Transgenic smooth muscle expression of the human CysLT1 receptor induces enhanced responsiveness of murine airways to leukotriene D4. Am. J. Physiol. Lung Cell. Mol. Physiol.
286: L992-L1001
[Abstract][Full Text]
Mandal, A. K., Skoch, J., Bacskai, B. J., Hyman, B. T., Christmas, P., Miller, D., Yamin, T.-t. D., Xu, S., Wisniewski, D., Evans, J. F., Soberman, R. J.
(2004). The membrane organization of leukotriene synthesis. Proc. Natl. Acad. Sci. USA
101: 6587-6592
[Abstract][Full Text]
Steinke, J. W., Crouse, C. D., Bradley, D., Hise, K., Lynch, K., Kountakis, S. E., Borish, L.
(2004). Characterization of Interleukin-4-Stimulated Nasal Polyp Fibroblasts. Am. J. Respir. Cell Mol. Bio.
30: 212-219
[Abstract][Full Text]
Zembowicz, A., Mastalerz, L., Setkowicz, M., Radziszewski, W., Szczeklik, A.
(2003). Safety of Cyclooxygenase 2 Inhibitors and Increased Leukotriene Synthesis in Chronic Idiopathic Urticaria With Sensitivity to Nonsteroidal Anti-inflammatory Drugs. Arch Dermatol
139: 1577-1582
[Abstract][Full Text]
Miotto, D., Ruggieri, M.P., Boschetto, P., Cavallesco, G., Papi, A., Bononi, I., Piola, C., Murer, B., Fabbri, L.M., Mapp, C.E.
(2003). Interleukin-13 and -4 expression in the central airways of smokers with chronic bronchitis. Eur Respir J
22: 602-608
[Abstract][Full Text]
Jenkins, S
(2003). Leukotriene receptors are overexpressed in aspirin sensitive asthmatics. Thorax
58: 105-105
[Full Text]
Arm, J. P., Austen, K. F.
(2002). Leukotriene Receptors and Aspirin Sensitivity. NEJM
347: 1524-1526
[Full Text]